Strongholds, qualities and future for Nordic Life Science

Panel: Christopher W. Uhde, Pharma & Biotech Analyst, Equity Research, SEB, Alexander Mata, Principal, Eir Ventures, Ekaterina Gianelli, Partner, Inventure, Simon Turner, Partner, Sofinnova Partners